<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4801</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> https://doi.org/10.31782/IJCRR.2024.16802</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	A Cross Sectional Study on the Awareness and Participation of the General Population in Clinical Trials&#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Reddy</surname><given-names>Manisha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gobre</surname><given-names>Rakshanda</given-names></name></contrib><contrib contrib-type="author"><name><surname>Verma</surname><given-names>Shubhi</given-names></name></contrib><contrib contrib-type="author"><name><surname>K</surname><given-names>Vignesh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pal</surname><given-names>Chandana</given-names></name></contrib><contrib contrib-type="author"><name><surname>Swaminathan</surname><given-names>Jayanthi</given-names></name></contrib><contrib contrib-type="author"><name><surname>A.</surname><given-names>Anitha Rani</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>30</day><month>04</month><year>2024</year></pub-date><volume>8)</volume><issue/><fpage>2</fpage><lpage>6</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	Introduction: In recent years there has been a huge increase in clinical research, enrolling millions of Indians in clinical trials (CTs). The awareness of CTs plays a major role in making the informed decision to participate in CTs. Aim/Objective: Current study aimed to assess the awareness and perception of Clinical Trials among the General population. Methodology: A prospective, cross-sectional, questionnaire-based survey was conducted among general public. A pre-validated Questionnaire on the awareness of Clinical trials was used. Results: Overall 83.9% of the participants were aware of Clinical trials. Among 283 responders 51.24% were male. Among the general public, interestingly 52.65% of the participants knew about CTs before Covid. 77.38% believed that clinical trials are needed for society, however, 38.52% thought there’s risk involved in participating in a CTs, and 39.93% believed family/ relative will allow them to participate in the study. Majorty of the participants (84.45%) accepted that CTs are needed for the advancement of knowledge. Majority of the participants were aware that the risks and benefits of CTs will be mentioned clearly (61.23%) and 80.92% aware permissions/approvals needed for conducting any CTs. Nearly 47.70% are aware that anyone who is found eligible for the CT can participate (53%). However, more than half of the study population (52.30%) were anxious about the side effects. Conclusion: The current study data suggested that there is a lack of particular understanding about clinical trials among the general people. There is a need to raise awareness of Clinical Trials among the general public.&#13;
&#13;
</p></abstract><kwd-group><kwd>Clinical Trials (CTs)</kwd><kwd> Human Participants</kwd><kwd> Knowledge</kwd><kwd> Awareness</kwd><kwd> General public</kwd><kwd> Perception</kwd></kwd-group></article-meta></front></article>
